Evidence map›Paper›PMID 37237812›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Combating Microbial Infections Using Metal-Based Nanoparticles as Potential Therapeutic Alternatives.

Rajwinder Kaur, Kirandeep Kaur, Mohammad H Alyami, Damanpreet Kaur Lang, Balraj Saini, Mohammad F Bayan, Balakumar Chandrasekaran

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. RSC advances · 2025
    Review
  5. Review
  6. Unveiling the Potential of CuO and CuNanomaterials (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Nanoarchitectonics for synergistic activity of multimetallic nanohybrids as a possible approach for antimicrobial resistance (AMR).Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Review
  9. EnhancedCurrent medical mycology · 2023
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Rajwinder KaurChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.ORCID 0000-0002-1697-9562
Kirandeep KaurDepartment of Clinical Safety and Pharmacovigilance, Soterius India Private Limited, Nehru Place, Delhi 110019, India.
Mohammad H AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.ORCID 0000-0003-2731-1071
Damanpreet Kaur LangChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Balraj SainiChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Mohammad F BayanFaculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0002-1736-1799
Balakumar ChandrasekaranFaculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0003-4198-8679
Chitkara University · INPhiladelphia University · JONajran University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nature of microorganisms and the efficiency of antimicrobials have witnessed a huge co-dependent change in their dynamics over the last few decades. On the other side, metals and metallic compounds have gained popularity owing to their effectiveness against various microbial strains. A structured search of both research and review papers was conducted via different electronic databases, such as PubMed, Bentham, Springer, and Science Direct, among others, for the present review. Along with these, marketed products, patents, and Clinicaltrials.gov were also referred to for our review. Different microbes such as bacteria, fungi, etc., and their diverse species and strains have been reviewed and found to be sensitive to metal-carrying formulations. The products are observed to restrict growth, multiplication, and biofilm formation effectively and adequately. Silver has an apt use in this area of treatment and recovery, and other metals like copper, gold, iron, and gallium have also been observed to generate antimicrobial activity. The present review identified membrane disruption, oxidative stress, and interaction with proteins and enzymes to be the primary microbicidal processes. Elaborating the action, nanoparticles and nanosystems are shown to work in our favor in well excelled and rational ways.

Indexed as

antimicrobial actionbiofilm formation inhibitorsmetalsmicrobicidalnanoparticles

Identifiers

PMID37237812
PMCPMC10215692
OpenAlexW4378515670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.